We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+9.7%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$6.58B
AUM Growth
-$16.9M
Cap. Flow
-$345M
Cap. Flow %
-5.24%
Top 10 Hldgs %
19.23%
Holding
670
New
207
Increased
92
Reduced
126
Closed
222

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$119M
2
ADI icon
Analog Devices
ADI
+$91.5M
3
PAYC icon
Paycom
PAYC
+$76.8M
4
PANW icon
Palo Alto Networks
PANW
+$71M
5
AZEK
The AZEK Co
AZEK
+$59.1M

Top Sells

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$142M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$122M
3
CRM icon
Salesforce
CRM
+$101M
4
PFPT
Proofpoint, Inc.
PFPT
+$80.9M
5
TWLO icon
Twilio
TWLO
+$72M

Sector Composition

Rank Sector Weight
1 Technology 22.89%
2 Healthcare 14.97%
3 Industrials 11.6%
4 Consumer Discretionary 11.16%
5 Financials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BILL icon
326
BILL Holdings
BILL
$4.91B
$2.51M 0.04%
25,000
-180,302
-88% -$16.4M
BLDR icon
327
Builders FirstSource
BLDR
$7.74B
$2.47M 0.04%
+75,650
New +$2.05M
AERI
328
DELISTED
Aerie Pharmaceuticals
AERI
$2.45M 0.04%
208,203
– –
STLN
329
Starling Oncology, Inc. Common Stock
STLN
$628M
$2.44M 0.04%
+235,448
New +$2.45M
CD
330
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$2.44M 0.04%
+150,000
New +$2.43M
ATYR
331
aTyr Pharma
ATYR
$51.9M
$2.43M 0.04%
752,646
+26,662
+4% +$109K
FIRY
332
Firy Inc
FIRY
$164M
$2.4M 0.04%
+9,889
New +$2.27M
CLOVW
333
DELISTED
Clover Health Investments, Corp. Warrants
CLOVW
$2.39M 0.04%
+191,895
New +$600K
NREF
334
NexPoint Real Estate Finance
NREF
$322M
$2.39M 0.04%
162,811
-14,944
-8% -$228K
ADMA icon
335
ADMA Biologics
ADMA
$2.18B
$2.32M 0.04%
969,547
+677,001
+231% +$1.86M
LSF icon
336
Laird Superfood
LSF
$48.1M
$2.29M 0.03%
+50,000
New +$2.16M
CELL
337
DELISTED
PhenomeX Inc. Common Stock
CELL
$2.29M 0.03%
+30,000
New +$1.91M
OM icon
338
Outset Medical
OM
$92.7M
$2.27M 0.03%
+3,032
New +$2.49M
CERE
339
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$2.26M 0.03%
+216,453
New +$2.28M
LVOXW
340
DELISTED
LiveVox Holding, Inc. Warrant
LVOXW
$2.16M 0.03%
215,223
– –
FLEX icon
341
Flex
FLEX
$44.2B
$2.16M 0.03%
257,340
-2,306,894
-90% -$18.8M
FVAC.WS
342
DELISTED
Fortress Value Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A c
FVAC.WS
$2.15M 0.03%
+158,466
New +$481K
IDYA icon
343
IDEAYA Biosciences
IDYA
$3.54B
$2.15M 0.03%
170,788
-50,000
-23% -$619K
HECCU
344
DELISTED
Hudson Executive Investment Corp. Units
HECCU
$2.13M 0.03%
203,340
-99,999
-33% -$1.03M
ETNB
345
DELISTED
89bio
ETNB
$2.11M 0.03%
+82,376
New +$2.61M
FIIIU
346
DELISTED
Forum Merger III Corporation Units
FIIIU
$2.11M 0.03%
+202,404
New +$2.06M
CPSR.U
347
DELISTED
Capstar Special Purpose Acquisition Corp. Units, each consisting of one share of Class A Common Stoc
CPSR.U
$2.07M 0.03%
+203,202
New +$2.07M
UTI icon
348
Universal Technical Institute
UTI
$1.47B
$2.07M 0.03%
+407,512
New +$2.86M
ATRA icon
349
Atara Biotherapeutics
ATRA
$77.6M
$2.06M 0.03%
6,356
-2,722
-30% -$927K
TCDA
350
DELISTED
Tricida, Inc. Common Stock
TCDA
$2.05M 0.03%
226,188
+26,300
+13% +$384K
12 13
14
15 16

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q3 2020 Portfolio in Review

As of Q3 2020, Alyeska Investment Group held 670 positions worth $6.58B, down 0.26% from $6.59B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Alyeska Investment Group withdrew a net $345M in Q3 2020, closing 222 positions and reducing 126 holdings. Its most notable exit was Texas Instruments, an estimated $142M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alyeska Investment Group opened a new position in Microsoft worth $119M.

  • Alyeska Investment Group's largest Q3 2020 buy was Microsoft: 568,147 shares worth $119M.
  • Alyeska Investment Group added most to Paycom in Q3 2020, an estimated $76.8M increase.
  • Alyeska Investment Group's biggest Q3 2020 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Alyeska Investment Group fully exited Texas Instruments in Q3 2020, selling an estimated $142M.
  • Alyeska Investment Group's ten largest holdings make up 19% of its $6.58B portfolio in Q3 2020.
  • Alyeska Investment Group opened 207 new positions and closed 222 in Q3 2020.
  • Alyeska Investment Group's portfolio value fell 0.26% quarter-over-quarter to $6.58B.

Based on Alyeska Investment Group's 13F filing for Q3 2020, filed 16 Nov 2020.